Your browser doesn't support javascript.
loading
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers.
Marras, C; Schüle, B; Schuele, B; Munhoz, R P; Rogaeva, E; Langston, J W; Kasten, M; Meaney, C; Klein, C; Wadia, P M; Lim, S-Y; Chuang, R S-I; Zadikof, C; Steeves, T; Prakash, K M; de Bie, R M A; Adeli, G; Thomsen, T; Johansen, K K; Teive, H A; Asante, A; Reginold, W; Lang, A E.
Affiliation
  • Marras C; Toronto Western Hospital, Edmond J. Safra Program in Parkinson's Disease, Toronto, ON M5T 2S8 Canada. cmarras@uhnresearch.ca
Neurology ; 77(4): 325-33, 2011 Jul 26.
Article in En | MEDLINE | ID: mdl-21753163

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Phenotype / Protein Serine-Threonine Kinases / Genetic Predisposition to Disease / Heterozygote / Mutation Type of study: Prognostic_studies / Screening_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2011 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Phenotype / Protein Serine-Threonine Kinases / Genetic Predisposition to Disease / Heterozygote / Mutation Type of study: Prognostic_studies / Screening_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2011 Document type: Article